Peripheral IV Catheters Market Overview
The peripheral intravenous (IV) catheter market is witnessing significant growth due to the increasing demand for safe and effective vascular access in both hospitals and outpatient care settings. Peripheral IV catheters are commonly used for intravenous drug administration, fluid infusion, and blood draws. They are essential for medical procedures that require immediate access to the bloodstream, such as emergency care, chemotherapy, and intensive care unit (ICU) treatments. The growing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, which often require long-term intravenous access, is driving the market’s expansion. In addition to this, the rising number of surgeries and medical procedures requiring intravenous access further contributes to the demand for peripheral IV catheters. The ongoing emphasis on improving patient safety and reducing complications associated with venous access has led to advancements in catheter design, such as longer dwell times and improved materials that reduce the risk of infection and phlebitis. As the healthcare industry continues to focus on improving patient outcomes, the peripheral IV catheter market is expected to see continued innovations, driving further demand for these essential medical devices.The peripheral IV catheter market has experienced notable advancements with the introduction of more advanced catheter designs aimed at improving patient comfort and reducing complications. New materials, such as antimicrobial coatings and improved biocompatibility, are being incorporated into catheters to prevent infections, a major concern with traditional IV catheter use. Moreover, the market is seeing the adoption of IV catheters with features such as closed intravenous systems that prevent air embolism and reduce the risk of bloodstream infections. Technological innovations such as smart IV catheters equipped with sensors to monitor parameters like pressure and temperature are gaining traction, providing real-time data to healthcare professionals for improved decision-making. The use of ultrasound-guided peripheral IV catheter insertion is becoming more common in clinical settings, offering higher precision and reducing the failure rates of catheter insertions, particularly in difficult-to-access veins. Additionally, the increasing focus on home healthcare and outpatient treatments is driving the adoption of small, portable IV catheters that can be easily used by caregivers outside of hospital environments. These advancements are expected to further fuel the growth of the peripheral IV catheter market in the coming years.
The peripheral IV catheter market is expected to experience further growth driven by continued innovations in catheter technology and materials. There is growing interest in developing catheters with longer dwell times, reducing the frequency of catheter replacements, which in turn reduces the risk of infection and enhances patient comfort. As the focus on patient-centric care increases, the market will see a greater emphasis on designing IV catheters that are easy to use and offer minimal discomfort, making them suitable for both hospital and homecare environments. Additionally, the integration of more advanced monitoring systems, including remote monitoring technologies, will allow healthcare providers to track the status of the catheter and ensure optimal performance. The expansion of outpatient clinics, home healthcare services, and ambulatory care centers will further fuel the demand for peripheral IV catheters, especially as the prevalence of chronic diseases continues to rise. Moreover, with advancements in nanotechnology, there may be opportunities to develop more efficient and infection-resistant IV catheters, revolutionizing the market by providing safer and more reliable vascular access solutions.
Key Insights: Peripheral Iv Catheters Market
- Advancements in Antimicrobial Coatings: The development of antimicrobial-coated catheters is helping reduce the risk of infections, making IV catheter use safer for patients.
- Integration of Smart Features and Sensors: Smart IV catheters equipped with sensors for monitoring temperature, pressure, and other parameters are improving real-time monitoring and patient care.
- Use of Ultrasound-Guided Insertion Techniques: The adoption of ultrasound-guided catheter insertions is enhancing accuracy and reducing complications, especially in difficult vascular access cases.
- Focus on Home Healthcare and Outpatient Services: The growing trend of home healthcare and outpatient treatments is driving demand for portable, user-friendly IV catheters that are easy to use in non-clinical settings.
- Increased Adoption of Closed IV Systems: The market is seeing more adoption of closed intravenous systems that reduce the risk of bloodstream infections and air embolism during fluid administration.
- Increasing Prevalence of Chronic Diseases: The rise in chronic diseases such as cancer, diabetes, and cardiovascular disorders is contributing to the demand for peripheral IV catheters for long-term vascular access.
- Growth in Outpatient and Home Healthcare Services: The shift towards homecare and outpatient treatments is increasing the demand for peripheral IV catheters that are easy to use in non-hospital environments.
- Technological Advancements in Catheter Design: Innovations in catheter materials, antimicrobial coatings, and smart technologies are driving market growth by improving patient safety and comfort.
- Focus on Patient Safety and Infection Control: Healthcare providers' increased focus on reducing infection risks and improving patient outcomes is fueling demand for advanced, safe IV catheters.
- Risk of Infection and Complications from Frequent Use: Despite advancements in catheter design, the risk of infection, phlebitis, and other complications remains a challenge, requiring continuous innovation in materials and techniques to ensure patient safety.
Peripheral Iv Catheters Market Segmentation
By Product Type
- Short Peripheral Intravenous Catheters
- Integrated/Closed Peripheral Intravenous Catheters (PIVC)
By Technology
- Conventional Peripheral Intravenous Catheters (PIVC)
- Safety Peripheral Intravenous Catheters (PIVC)
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Healthcare
Key Companies Analysed
- Cargill Incorporated
- Agridient Inc.
- Axiom Foods Ltd.
- Norben Company Inc.
- Nutri Pea Ltd.
- Burcon NutraScience Corporation
- Cosucra Groupe Warcoing SA
- A & B Ingredients Inc.
- Shandong Jianyuan Foods Co. Ltd.
- Archer Daniels Midland Company
- Fenchem SA
- Kerry Group plc
- Prinova Group LLC
- Batory Foods Inc.
- PLT Health Solutions
- Glanbia plc
- AGT Food & Ingredients Inc.
- World Food Processing LLC
- Yantai T. Full Biotech Co. Ltd.
- Suzhou Wanshen Flour Products Co. Ltd.
- Ingredion Incorporated
- Cambridge Commodities Inc.
- Consucra-Groupe Warcoing SA
- Roquette Freres Le Romarin SA
- Green Labs LLC
- GEMEF Industries
- Puris Proteins LLC.
- Tate & Lyle Inc.
- Emsland-Starke Gmbh
- DuPont de Nemours Inc.
Peripheral Iv Catheters Market Analytics
The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.
Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.Peripheral Iv Catheters Market Competitive Intelligence
The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.
Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.Countries Covered
- North America - Peripheral Iv Catheters market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Peripheral Iv Catheters market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
- Asia-Pacific - Peripheral Iv Catheters market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Peripheral Iv Catheters market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Peripheral Iv Catheters market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Research Methodology
This study combines primary inputs from industry experts across the Peripheral Iv Catheters value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.Key Questions Addressed
- What is the current and forecast market size of the Peripheral Iv Catheters industry at global, regional, and country levels?
- Which types, applications, and technologies present the highest growth potential?
- How are supply chains adapting to geopolitical and economic shocks?
- What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
- Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
- Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
- Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?
Your Key Takeaways from the Peripheral Iv Catheters Market Report
- Global Peripheral Iv Catheters market size and growth projections (CAGR), 2024-2034
- Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Peripheral Iv Catheters trade, costs, and supply chains
- Peripheral Iv Catheters market size, share, and outlook across 5 regions and 27 countries, 2023-2034
- Peripheral Iv Catheters market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
- Short- and long-term Peripheral Iv Catheters market trends, drivers, restraints, and opportunities
- Porter’s Five Forces analysis, technological developments, and Peripheral Iv Catheters supply chain analysis
- Peripheral Iv Catheters trade analysis, Peripheral Iv Catheters market price analysis, and Peripheral Iv Catheters supply/demand dynamics
- Profiles of 5 leading companies - overview, key strategies, financials, and products
- Latest Peripheral Iv Catheters market news and developments
Additional Support
With the purchase of this report, you will receive:- An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
- Complimentary report update to incorporate the latest available data and the impact of recent market developments.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Cargill Incorporated
- Agridient Inc.
- Axiom Foods Ltd.
- Norben Company Inc.
- Nutri Pea Ltd.
- Burcon NutraScience Corporation
- Cosucra Groupe Warcoing SA
- A & B Ingredients Inc.
- Shandong Jianyuan Foods Co. Ltd.
- Archer Daniels Midland Company
- Fenchem SA
- Kerry Group PLC
- Prinova Group LLC
- Batory Foods Inc.
- PLT Health Solutions
- Glanbia PLC
- AGT Food & Ingredients Inc.
- World Food Processing LLC
- Yantai T. Full Biotech Co. Ltd.
- Suzhou Wanshen Flour Products Co. Ltd.
- Ingredion Incorporated
- Cambridge Commodities Inc.
- Consucra-Groupe Warcoing SA
- Roquette Freres Le Romarin SA
- Green Labs LLC
- GEMEF Industries
- Puris Proteins LLC.
- Tate & Lyle Inc.
- Emsland-Starke Gmbh
- DuPont de Nemours Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 7.1 Billion |
| Forecasted Market Value ( USD | $ 13.3 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |


